An ETF Chock Full of Pharma Takeover Candidates
July 30, 2015 at 08:00 AM EDT
Earlier this week, Israel’s Teva Pharmaceuticals (NasdaqGS: TEVA) said it will pay $40.5 billion for Allergan’s (NYSE: AGN) generic drugs unit, underscoring the notion that the healthcare sector remains white hot when it comes to mergers and acquisitions activity. A broad swath of...